Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria Grazia Lazzaroni, Enrico Colombo, Rucsandra Dobrota et al.|The Journal of Rheumatology|2017Cited by 127
Scleroderma and scleroderma-like syndromesKatarzyna Romanowska‐Próchnicka, Marzena Olesińska, Martyna Dziewit et al.|Frontiers in Immunology|2024Cited by 19
OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre StudyMaria Grazia Lazzaroni, Paolo Airó, Ilaria Cavazzana et al.|Annals of the Rheumatic Diseases|2016Cited by 0